SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank OZK

Bank OZK reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.8% in the 4th quarter, HoldingsChannel reports. The firm owned 3,972 shares of the exchange traded fund’s stock after selling 244 shares during the quarter. Bank OZK’s holdings in SPDR S&P Biotech ETF were worth $358,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Howard Capital Management Group LLC grew its stake in SPDR S&P Biotech ETF by 2.6% in the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after acquiring an additional 6,188 shares during the period. Financial Advocates Investment Management purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $1,300,000. Focus Financial Network Inc. purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $218,000. Pursue Wealth Partners LLC grew its stake in SPDR S&P Biotech ETF by 9.0% in the 3rd quarter. Pursue Wealth Partners LLC now owns 14,804 shares of the exchange traded fund’s stock worth $1,463,000 after acquiring an additional 1,227 shares during the period. Finally, Shepherd Financial Partners LLC grew its stake in SPDR S&P Biotech ETF by 14.2% in the 3rd quarter. Shepherd Financial Partners LLC now owns 10,450 shares of the exchange traded fund’s stock worth $1,032,000 after acquiring an additional 1,298 shares during the period.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $88.71 on Friday. The stock has a market capitalization of $5.85 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company has a 50 day moving average price of $91.00 and a two-hundred day moving average price of $95.76.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.